Abstract
Nearly all mass gathering events (MGEs) worldwide have been banned since the outbreak of SARS-CoV-2 as they are supposed to pose a considerable risk for transmission of COVID-19. We investigated transmission risk of SARS-CoV-2 by droplets and aerosols during an experimental indoor MGE (using N95 masks and contact tracing devices) and conducted a simulation study to estimate the resulting burden of disease under conditions of controlled epidemics. The number of exposed contacts was <10 for scenarios with hygiene concept and good ventilation, but substantially higher otherwise. Of subsequent cases, 0%-23% were attributable to MGEs. Overall, the expected additional effect of indoor MGEs on burden of infections is low if hygiene concepts are applied and adequate ventilation exists.
One Sentence Summary Seated indoor events, when conducted under hygiene precautions and with adequate ventilation, have small effects on the spread of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
German clinical trials register ID #: DRKS00022790
Funding Statement
Ministry of economics, science and digitalisation, federal state of Saxony-Anhalt and Ministry of science, culture and tourism, federal state of Saxony. None of the involved parties had any influence on the authors with respect to the study results and the decision to publish those.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Martin-Luther-University (Halle, Germany) approved the RESTART-19 study. The responsible authorities (Saechsisches Staatsministerium fuer Soziales und gesellschaftlichen Zusammenhalt) and the Public Health Authority of the city of Leipzig permitted the study according to the submitted hygiene and safety concept.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Most of the quantitative results are provided in the supplemental tables. Distributions and individual level data in anonymized form can be obtained upon request. Code of the simulation model is submitted as supplementary material.
